PSP Research LLC
- SEC CIK
- 0002106939
- 最新申報
- 2026/7/9
2026 年第 1 季持倉
持倉截至 2026/3/31，2026/4/17 申報。只含多頭部位，變化是跟 2025 年第 4 季比股數。
- 持股檔數
- 79
- 較 2025 年第 4 季 −6
- 總值
- $1.41 億
- 較 2025 年第 4 季 +$2,691 萬 (+23.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| iShares Tr46436E718 | 0-3 MTH TREASURY | 700,000 | $7,046 萬 | 49.9% | 00.0% | 不變 | – |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 284,900 | $3,639 萬 | 25.7% | +284,900 | 新進 | – |
| SERASera Prognostics, Inc. | CLASS A COM | 2,396,685 | $486.5 萬 | 3.4% | +2,396,685 | 新進 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | COM SHS | 34,800 | $65.8 萬 | 0.5% | −41−0.1% | 減碼 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 16,000 | $61.3 萬 | 0.4% | −5,853−26.8% | 減碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 2,500 | $57.2 萬 | 0.4% | −79−3.1% | 減碼 | 歷史 |
| PHVSPharvaris N.V. | COM | 20,000 | $56.5 萬 | 0.4% | −511−2.5% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 8,300 | $54.7 萬 | 0.4% | −13−0.2% | 減碼 | 歷史 |
| RPRXRoyalty Pharma plc | SHS CLASS A | 11,000 | $52.8 萬 | 0.4% | −2,826−20.4% | 減碼 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 6,300 | $52.5 萬 | 0.4% | −48−0.8% | 減碼 | 歷史 |
| HALOHalozyme Therapeutics, Inc. | COM | 8,026 | $51.9 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| EXELExelixis, Inc. | COM | 11,948 | $51.2 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| IRONDisc Medicine, Inc. | COM | 8,000 | $51.2 萬 | 0.4% | +8,000 | 新進 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 6,800 | $51.1 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| AGIOAgios Pharmaceuticals, Inc. | COM | 15,000 | $50.7 萬 | 0.4% | +15,000 | 新進 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 3,848 | $50.7 萬 | 0.4% | +114+3.1% | 加碼 | 歷史 |
| INCYIncyte Corp | COM | 5,300 | $49.9 萬 | 0.4% | −50−0.9% | 減碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 7,000 | $49.1 萬 | 0.3% | +481+7.4% | 加碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 15,000 | $48.8 萬 | 0.3% | +286+1.9% | 加碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 1,465 | $48.5 萬 | 0.3% | +147+11.2% | 加碼 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 1,500 | $48.3 萬 | 0.3% | −482−24.3% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 2,845 | $48.1 萬 | 0.3% | +2,845 | 新進 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 15,000 | $48.0 萬 | 0.3% | +80+0.5% | 加碼 | 歷史 |
| ARDXArdelyx, Inc. | COM | 80,000 | $47.9 萬 | 0.3% | +80,000 | 新進 | 歷史 |
| IMVTImmunovant, Inc. | COM | 19,200 | $47.7 萬 | 0.3% | −1,105−5.4% | 減碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 641 | $46.8 萬 | 0.3% | +11+1.7% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 20,000 | $46.7 萬 | 0.3% | −4,716−19.1% | 減碼 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 6,927 | $46.6 萬 | 0.3% | +538+8.4% | 加碼 | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 19,700 | $46.4 萬 | 0.3% | +984+5.3% | 加碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 22,100 | $46.3 萬 | 0.3% | +22,100 | 新進 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 5,000 | $46.2 萬 | 0.3% | −1,854−27.0% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 12,000 | $46.2 萬 | 0.3% | −1,233−9.3% | 減碼 | 歷史 |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 28,000 | $46.1 萬 | 0.3% | +28,000 | 新進 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 15,141 | $45.7 萬 | 0.3% | +717+5.0% | 加碼 | 歷史 |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 9,500 | $45.2 萬 | 0.3% | −80−0.8% | 減碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 6,000 | $44.6 萬 | 0.3% | −1,140−16.0% | 減碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 28,700 | $44.5 萬 | 0.3% | −130.0% | 減碼 | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 30,000 | $44.5 萬 | 0.3% | −3,953−11.6% | 減碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 19,766 | $44.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| RAPPRapport Therapeutics, Inc. | COM | 14,000 | $43.8 萬 | 0.3% | −3,506−20.0% | 減碼 | 歷史 |
| IMNMImmunome Inc. | COM | 20,000 | $43.7 萬 | 0.3% | −5,245−20.8% | 減碼 | 歷史 |
| KNSAKiniksa Pharmaceuticals International, plc | ORD SHS CL A | 9,000 | $43.3 萬 | 0.3% | −3,655−28.9% | 減碼 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 13,000 | $43.2 萬 | 0.3% | −4,807−27.0% | 減碼 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 5,000 | $42.0 萬 | 0.3% | −7,725−60.7% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 13,000 | $41.2 萬 | 0.3% | −7,368−36.2% | 減碼 | 歷史 |
| PTCTPTC Therapeutics, Inc. | COM | 6,000 | $40.9 萬 | 0.3% | −1,046−14.8% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 10,000 | $40.2 萬 | 0.3% | +40.0% | 加碼 | 歷史 |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 14,283 | $40.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 11,000 | $40.0 萬 | 0.3% | −316−2.8% | 減碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 71,000 | $39.3 萬 | 0.3% | +71,000 | 新進 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 12,000 | $39.1 萬 | 0.3% | −4,621−27.8% | 減碼 | 歷史 |
| KODKodiak Sciences Inc. | COM | 10,000 | $38.1 萬 | 0.3% | −9,418−48.5% | 減碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 20,000 | $36.3 萬 | 0.3% | −1,535−7.1% | 減碼 | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 30,000 | $35.8 萬 | 0.3% | +30,000 | 新進 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 26,900 | $34.5 萬 | 0.2% | +26,900 | 新進 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 3,000 | $31.6 萬 | 0.2% | −3,121−51.0% | 減碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 600 | $31.4 萬 | 0.2% | −292−32.7% | 減碼 | 歷史 |
| SUPNSupernus Pharmaceuticals, Inc. | COM | 6,000 | $31.0 萬 | 0.2% | −4,758−44.2% | 減碼 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 14,400 | $30.1 萬 | 0.2% | +14,400 | 新進 | 歷史 |
| ERASErasca, Inc. | COM | 17,327 | $28.0 萬 | 0.2% | +17,327 | 新進 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 7,000 | $27.4 萬 | 0.2% | +7,000 | 新進 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 5,159 | $26.0 萬 | 0.2% | −10,681−67.4% | 減碼 | 歷史 |
| ZYMEZymeworks Inc. | COM | 10,000 | $25.0 萬 | 0.2% | −10,312−50.8% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 4,200 | $24.4 萬 | 0.2% | −7,478−64.0% | 減碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 4,968 | $24.4 萬 | 0.2% | +4,968 | 新進 | 歷史 |
| CELCCelcuity Inc. | COM | 2,000 | $22.8 萬 | 0.2% | −3,244−61.9% | 減碼 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 10,795 | $21.7 萬 | 0.2% | +10,795 | 新進 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 12,000 | $21.7 萬 | 0.2% | −12,397−50.8% | 減碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 6,000 | $21.2 萬 | 0.2% | −13,280−68.9% | 減碼 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 2,500 | $21.0 萬 | 0.1% | −4,484−64.2% | 減碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 350 | $20.8 萬 | 0.1% | −730−67.6% | 減碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 6,500 | $20.5 萬 | 0.1% | +6,500 | 新進 | 歷史 |
| SMMTSummit Therapeutics Inc. | COM | 10,223 | $19.4 萬 | 0.1% | +10,223 | 新進 | 歷史 |
| ORICOric Pharmaceuticals, Inc. | COM | 13,000 | $16.5 萬 | 0.1% | +13,000 | 新進 | 歷史 |
| CMPXCompass Therapeutics, Inc. | COM | 30,000 | $15.9 萬 | 0.1% | +30,000 | 新進 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 10,838 | $15.1 萬 | 0.1% | −33,385−75.5% | 減碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 10,000 | $14.9 萬 | 0.1% | −9,063−47.5% | 減碼 | 歷史 |
| EYPTEyePoint, Inc. | COM NEW | 10,000 | $12.9 萬 | 0.1% | −19,530−66.1% | 減碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 15,000 | $12.7 萬 | 0.1% | −27,853−65.0% | 減碼 | 歷史 |
2025 年第 4 季之後清倉（26 檔）
2025 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 4 季股數 | 2025 年第 4 季市值 | 2025 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | COM | 15,272 | $58.4 萬 | 0.5% | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 3,258 | $55.4 萬 | 0.5% | 歷史 |
| CGONCG Oncology, Inc. | COM | 13,293 | $55.2 萬 | 0.5% | 歷史 |
| BLTEBelite Bio, Inc | SPONSORED ADS | 3,443 | $55.1 萬 | 0.5% | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 21,866 | $54.9 萬 | 0.5% | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 13,560 | $54.8 萬 | 0.5% | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 6,872 | $54.7 萬 | 0.5% | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 21,879 | $54.7 萬 | 0.5% | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 14,818 | $53.8 萬 | 0.5% | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 8,224 | $53.6 萬 | 0.5% | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 24,621 | $53.4 萬 | 0.5% | 歷史 |
| LQDALiquidia Corp | COM NEW | 15,485 | $53.4 萬 | 0.5% | 歷史 |
| PVLAPalvella Therapeutics, Inc. | COM | 5,084 | $53.2 萬 | 0.5% | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 3,049 | $53.1 萬 | 0.5% | 歷史 |
| NUVLNuvalent, Inc. | COM | 5,261 | $52.9 萬 | 0.5% | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 16,967 | $52.8 萬 | 0.5% | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 31,040 | $52.8 萬 | 0.5% | 歷史 |
| MAZEMaze Therapeutics, Inc. | COM | 12,672 | $52.5 萬 | 0.5% | 歷史 |
| DNLIDenali Therapeutics Inc. | COM | 31,762 | $52.4 萬 | 0.5% | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 8,772 | $52.1 萬 | 0.5% | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 18,334 | $50.8 萬 | 0.4% | 歷史 |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 4,738 | $50.7 萬 | 0.4% | 歷史 |
| UPBUpstream Bio, Inc. | COM | 17,634 | $47.9 萬 | 0.4% | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 6,719 | $46.7 萬 | 0.4% | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 6,689 | $44.4 萬 | 0.4% | 歷史 |
| ALMSAlumis Inc. | COM | 43,769 | $42.7 萬 | 0.4% | 歷史 |